Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Ampullary Adenocarcinoma × Fluorouracil × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 5 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Recurrence 1 Pseudomyxoma Peritonei 1 Peritoneal Neoplasms 1 Neutropenia 1 Neoplastic Cells, Circulating 1 Muscle Neoplasms 1 Mesothelioma 1 Locally Advanced Pancreatic Adenocarcinoma 1 Liver Neoplasms 1 Keratosis, Actinic 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Chronic Pain 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Breast Cancer Organoids 1 Biliary Tract Neoplasms 1 Ampullary Adenocarcinoma 1

Interventions

folfirinox 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06068023 2023-10-05

ADAPTA

Fondazione Poliambulanza Istituto Ospedaliero

Ampullary Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡